Doskas, T.; Vavougios, G.D.; Kormas, C.; Kokkotis, C.; Tsiptsios, D.; Spiliopoulos, K.C.; Tsiakiri, A.; Christidi, F.; Aravidou, T.; Dekavallas, L.;
et al. Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease. Brain Sci. 2025, 15, 564.
https://doi.org/10.3390/brainsci15060564
AMA Style
Doskas T, Vavougios GD, Kormas C, Kokkotis C, Tsiptsios D, Spiliopoulos KC, Tsiakiri A, Christidi F, Aravidou T, Dekavallas L,
et al. Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease. Brain Sciences. 2025; 15(6):564.
https://doi.org/10.3390/brainsci15060564
Chicago/Turabian Style
Doskas, Triantafyllos, George D. Vavougios, Constantinos Kormas, Christos Kokkotis, Dimitrios Tsiptsios, Kanellos C. Spiliopoulos, Anna Tsiakiri, Foteini Christidi, Tamara Aravidou, Liberis Dekavallas,
and et al. 2025. "Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease" Brain Sciences 15, no. 6: 564.
https://doi.org/10.3390/brainsci15060564
APA Style
Doskas, T., Vavougios, G. D., Kormas, C., Kokkotis, C., Tsiptsios, D., Spiliopoulos, K. C., Tsiakiri, A., Christidi, F., Aravidou, T., Dekavallas, L., Kazis, D., Dardiotis, E., & Vadikolias, K.
(2025). Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease. Brain Sciences, 15(6), 564.
https://doi.org/10.3390/brainsci15060564
